ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
In Vitro Monitoring of Babesia microti Infection Dynamics in Whole Blood Microenvironments.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Babesia microti: Breaking the culture barrier.Trends in parasitology · 2026Review
- Acquired motility ofProceedings of the National Academy of Sciences of the United States of America · 2026Article
- Natural products against Babesiosis: active compounds, molecular mechanisms, application limitations and translational development.Frontiers in cellular and infection microbiology · 2026Review
- In Vitro Monitoring of Babesia microti Infection Dynamics in Whole Blood Microenvironments.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Babesiosis - a globally emerging tick-borne infectious disease primarily caused by the intraerythrocytic piroplasm parasite, Babesia microti - has traditionally been studied using animal models such as mice. Compared to animal models, microfluidic-based models offer advantages, including direct analysis of human samples (such as patient blood), enhanced assay capacity (including physical/optical access, consistency, and throughput), low costs, and easy adoption. Here, an open microfluidic platform named "µ-Blood" is reported for real-time continuous monitoring B. microti infection dynamics in vitro. Compared to other microfluidic-based models, µ-Blood allows direct examination of infected and uninfected whole blood without preprocessing steps like blood dilution or cell isolation, minimizing observer artifacts and preserving the natural whole blood microenvironment. The system enables extended (72 h) monitoring of infection dynamics, including parasite identification, parasitemia measurement, and parasite-host cell interactions, using label-free phase contrast and fluorescence confocal microscopy. With its open microfluidic configuration, µ-Blood provides an in vitro model for studying blood-borne infection dynamics while maintaining integrity of the whole blood microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.